EZH2 and glioblastoma: Understanding the regulatory relationships between miRNAs and EZH2 in GBM may provide insights into the underlying biology of the disease and potentially open avenues for novel therapeutic strategies, such as utilizing miRNAs to modulate EZH2 or targeting EZH2 directly as a therapeutic intervention.